Avalor Therapeutics
Kenmore, US · Founded 2020
Biotech
Founders & leadership
WE
William E. Martinez ZegarraExecutive Officer, Director
AF
Anthony FordDirector
KW
Kenneth WildDirector
Reported raises · per SEC filings
Form D private placements▶$335KraisedDec 2023 · 6 investors · BiotechnologyRule 506(b)
▶$335KraisedDec 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William E. Martinez ZegarraExecutive Officer, Director
- Anthony FordDirector
- Kenneth WildDirector
- Offering amount
- $800K
- Amount sold
- $335K
- Minimum investment
- $25K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.